scorecard

You Searched For "DCGI" and got 18 results


Sort By:


Business Insider Latest Story Image
3 mins read

PresVu eye drops: Why has a pharma company fallen in controversy for claiming to cure near-sightedness?

PresVu has been suspended by the DCGI due to misleading marketing claims that the eye drops can "cu…

Business Insider Latest Story Image
1 min read

DCGI grants regular market approval for Covishield, Covaxin with conditions

In a subsequent tweet, the health minister said, "The conditions include supply for programm…

Business Insider Latest Story Image
2 mins read

Serum Institute seeks drug regulator's approval to start booster doses of Covishield

"People of our country as well as citizens of other countries who have already been fully va…

PTI   


Business Insider Latest Story Image
2 mins read

In India, less than one in every 10,000 jabs have led to serious adverse reactions — not necessarily due to the vaccine

The Ministry said the percentage of such effect having serious/severe (including deaths) in ca…

Business Insider Latest Story Image
3 mins read

Zydus Cadila’s COVID-19 vaccine for kids above 12 gets approval from India’s drug regulator

With Emergency Use Authorisation (EUA), ZyCoV-D has also become the first vaccine to be administ…

PTI   


Business Insider Latest Story Image
2 mins read

Around 10 crore doses of Covishield to be manufactured and supplied in June, says Serum Institute of India

In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working …

PTI   


Business Insider Latest Story Image
2 mins read

Serum Institute's Covovax gets DCGI approval as a heterologous booster dose

"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommende…

PTI   


Business Insider Latest Story Image
1 min read

Vaccine: DCGI panel to meet Bharat Biotech officials shortly

New Delhi, Jan 2 (IANS) A committee of experts assessing the coronavirus vaccines has called Hydera…

Business Insider Latest Story Image
1 min read

Bharat Biotech gets permission to manufacture covid 19 vaccine 'covaxin' for sale

New Delhi, Jan 3 (IANS) The Central Licensing Authority on Saturday granted permission to Hyderabad…

Business Insider Latest Story Image
4 mins read

Covishield and Covaxin are the first two Covid-19 vaccines to be approved in India

"After adequate examination, the CDSCO has decided to accept the recommendations of the Subject…

Business Insider Latest Story Image
2 mins read

India approves 2 Covid vaccines for emergency use

Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller Gen…

Business Insider Latest Story Image
3 mins read

A drug activists' group says it is 'baffled' by the approval given to Bharat Biotech's Covaxin

The All India Drug Action Network (AIDAN) said it is shocked to learn of the SEC's recommendation t…

Business Insider Latest Story Image
2 mins read

Giant leap for innovation: Bharat Biotech after DCGI approval to Covaxin

Hyderabad, Jan 3 (IANS) Bharat Biotech on Sunday said the approval for emergency use of its Covid-1…

Business Insider Latest Story Image
3 mins read

DCGI approves Serum, Bharat Biotech vaccine for emergency use (Ld)

New Delhi, Jan 3 (IANS) Eleven months after the first case of deadly coronavirus was detected in In…

Business Insider Latest Story Image
1 min read

Bharat Biotech seeks DCGI's nod to conduct nasal Covid vaccine trials

New Delhi, Jan 8 (IANS) Days after getting Drugs Controller General of India's (DCGI) nod for India…

Business Insider Latest Story Image
2 mins read

DCGI gives nod to India's first indigenous mRNA vaccine for human trial

New Delhi, Dec 11 (IANS) India's first indigenous mRNA vaccine candidate has received approval from…

Business Insider Latest Story Image
2 mins read

New Covid-19 drug gets DCGI's nod for human trial

New Delhi, Sep 11 (IANS) Amid the raging coronavirus pandemic, PNB Vesper Life Science Private Limi…

Business Insider Latest Story Image
2 mins read

DCGI gives nod to Serum Institute of India for phase 2 and 3 human clinical trials of the Oxford COVID-19 vaccine candidate

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the C…

PTI